Skip to main content
. 2018 Jan 17;19(1):282. doi: 10.3390/ijms19010282

Table 3.

Formulation in CRT-solution, mCMFC, and nCMFC.

Formulation MH Particles Carteolol MC BAC Mannitol Treatment
CRT-solution 1% 0.5% 0.001% 0.5%
mCMFC 0.01% 1% 0.5% 0.001% 0.5%
nCMFC 0.01% 1% 0.5% 0.001% 0.5% Bead mill

mCMFC, carteolol/MH microparticles fixed combination. nCMFC, carteolol/MH nanoparticles fixed combination. MC, methylcellulose. BAC, benzalkonium chloride.